SignatureFD’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.7K | Buy |
1,198
+805
| +205% | +$13.9K | ﹤0.01% | 2031 |
|
|
2025
Q1 | $8.6K | Sell |
393
-782
| -67% | -$17.1K | ﹤0.01% | 2398 |
|
|
2024
Q4 | $37.5K | Buy |
1,175
+918
| +357% | +$29.3K | ﹤0.01% | 1722 |
|
|
2024
Q3 | $7.41K | Sell |
257
-99
| -28% | -$2.86K | ﹤0.01% | 2448 |
|
|
2024
Q2 | $13.7K | Sell |
356
-731
| -67% | -$28K | ﹤0.01% | 2135 |
|
|
2024
Q1 | $63.9K | Buy |
1,087
+416
| +62% | +$24.5K | ﹤0.01% | 1417 |
|
|
2023
Q4 | $40.2K | Buy |
671
+111
| +20% | +$6.64K | ﹤0.01% | 1576 |
|
|
2023
Q3 | $21.3K | Buy |
560
+391
| +231% | +$14.9K | ﹤0.01% | 1817 |
|
|
2023
Q2 | $15.4K | Buy |
169
+60
| +55% | +$5.47K | ﹤0.01% | 2019 |
|
|
2023
Q1 | $7.19K | Buy |
109
+34
| +45% | +$2.24K | ﹤0.01% | 2358 |
|
|
2022
Q4 | $3.88K | Sell |
75
-3
| -4% | -$155 | ﹤0.01% | 2575 |
|
|
2022
Q3 | $5K | Buy |
78
+27
| +53% | +$1.73K | ﹤0.01% | 2404 |
|
|
2022
Q2 | $2K | Sell |
51
-41
| -45% | -$1.61K | ﹤0.01% | 2696 |
|
|
2022
Q1 | $5K | Buy |
+92
| New | +$5K | ﹤0.01% | 2449 |
|
|
2021
Q1 | – | Sell |
-23
| Closed | -$1K | – | 2743 |
|
|
2020
Q4 | $1K | Buy |
+23
| New | +$1K | ﹤0.01% | 2369 |
|